Expression of TNF and TNF Receptors (p55 and p75) in the Rat Brain after Focal Cerebral Ischemia

Cerebral ischemia induces a rapid and dramatic up-regulation of tumor necrosis factor (TNF) protein and mRNA, but the cellular sources of TNF in the ischemic brain have not been defined. The diverse activities of TNF are mediated via ligand interaction with two distinct receptors, p55 and p75, which activate separate intracellular signal transduction pathways, leading to distinct biological effects. Since the effects of cerebral ischemia on TNF receptor (TNFR) expression are unknown, we examined the cellular localization and protein expression of TNF and its two receptors in the rat cerebral cortex in response to permanent middle cerebral artery (MCA) occlusion. The results indicate that focal cerebral ischemia up-regulates expression of TNF and both TNFRs within the ischemic cortex. The most abundant type of TNF irrimunoreactivity (ER) was a punctate and filamentous pattern of transected cellular processes; however, cell bodies of neurons, astrocytes, and microglia, as well as infiltrating polymorphonuclear (PMN) leukocytes also showed TNF IR. Brain vasculature displayed TNF IR not only within endothelial cells but also in the perivascular space. MCA occlusion induced significant up-regulation of TNF receptors, with p55 IR appearing within 6 hr, significantly before the appearance of p75 IR at 24 hr after the onset of ischemia. Since p55 has been implicated in transducing cytotoxic signalling of TNF, these results support the proposed injurious role of excessive TNF produced during the acute response to cerebral ischemia.

[1]  M. Mattson,et al.  Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis , 1994, Neuron.

[2]  R. Rothlein,et al.  Monoclonal Antibody to the ICAM-1 Adhesion Site Reduces Neurological Damage in a Rabbit Cerebral Embolism Stroke Model , 1993, Experimental Neurology.

[3]  C. Saper,et al.  Distribution and characterization of tumor necrosis factor‐α‐like immunoreactivity in the murine central nervous system , 1993 .

[4]  S. Deutsch,et al.  Genomic structure, induction, and production of TNF-alpha. , 1992, Immunology series.

[5]  K. Tracey,et al.  TUMOR NECROSIS FACTOR IS A BRAIN DAMAGING CYTOKINE IN CEREBRAL ISCHEMIA , 1997, Shock.

[6]  R. Rothlein,et al.  Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. , 1991, Journal of neurosurgery.

[7]  L. Tartaglia,et al.  The two different receptors for tumor necrosis factor mediate distinct cellular responses. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  F. Barone,et al.  Brain Injury and Inflammation. A Putative Role of TNFα , 1995 .

[9]  K. Tracey,et al.  Cerebroprotective effects of aminoguanidine in a rodent model of stroke. , 1996, Stroke.

[10]  D. Wallach,et al.  Increased expression of tumor necrosis factor-alpha receptors in the brains of patients with AIDS. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[11]  L. Moldawer,et al.  Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Young,et al.  Tumor necrosis factor-alpha expression in ischemic neurons. , 1994, Stroke.

[13]  M. T. Shipley,et al.  Soman‐induced seizures rapidly activate astrocytes and microglia in discrete brain regions , 1997, The Journal of comparative neurology.

[14]  David A. Martin,et al.  Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat , 1996, Neuroscience Letters.

[15]  K. Tracey,et al.  Peptide Regulatory Factors CACHECTIN/TUMOUR NECROSIS FACTOR , 1989, The Lancet.

[16]  Y. Itoyama,et al.  Astroglial and microglial reactions in the gerbil hippocampus with induced ischemic tolerance , 1994, Brain Research.

[17]  J. Szaflarski,et al.  Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats. , 1995, Stroke.

[18]  M. Tada,et al.  Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction. , 1994, Journal of neurosurgery.

[19]  D. Banner,et al.  Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation , 1993, Cell.

[20]  Terry Farrah,et al.  The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death , 1994, Cell.

[21]  E. Maggi,et al.  Membrane tumour necrosis factor-α is involved in the polyclonal B-cell activation induced by HIV-infected human T cells , 1993, Nature.

[22]  F. Barone,et al.  Brain injury and inflammation. A putative role of TNF alpha. , 1995, Annals of the New York Academy of Sciences.

[23]  J. Barrett,et al.  Neurotoxic components in normal serum , 1992, Experimental Neurology.

[24]  R. Willette,et al.  Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. , 1997, Stroke.

[25]  J. Crocker,et al.  Ependymal cells of the choroid plexus express tumour necrosis factor‐α 1 , 1993, Neuropathology and applied neurobiology.

[26]  M. Brockhaus,et al.  Cell surface tumor necrosis factor (TNF) accounts for monocyte- and lymphocyte-mediated killing of TNF-resistant target cells. , 1989, Cellular immunology.

[27]  J. Merrill,et al.  Tumor necrosis factor identified in multiple sclerosis brain , 1989, The Journal of experimental medicine.

[28]  D. Wallach,et al.  Inhibition of Tumor Necrosis Factor Alpha (TNFα) Activity in Rat Brain is Associated with Cerebroprotection after Closed Head Injury , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  M. Shin,et al.  Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. Scheurich,et al.  TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. , 1993, Lymphokine and cytokine research.

[31]  P. Young,et al.  Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS. , 1996, Brain research. Molecular brain research.

[32]  K. Tracey,et al.  Cachectin/tumour necrosis factor. , 1989, Lancet.

[33]  J. Booss,et al.  Localization of TNF alpha and IL-1 alpha immunoreactivities in striatal neurons after surgical injury to the hippocampus. , 1993, Neuron.

[34]  Y. Shiga,et al.  Neutrophil as a mediator of ischemic edema formation in the brain , 1991, Neuroscience Letters.

[35]  G. Kollias,et al.  Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. , 1996, Journal of inflammation.

[36]  M. Chopp,et al.  Anti‐ICAM‐1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat , 1994, Neurology.

[37]  Y. Ushio,et al.  Microglial Response to Transient Focal Cerebral Ischemia: An Immunocytochemical Study on the Rat Cerebral Cortex Using Anti-Phosphotyrosine Antibody , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  L. Tartaglia,et al.  Two TNF receptors. , 1992, Immunology today.

[39]  H. Nawashiro,et al.  Inhibition of Tumor Necrosis Factor and Amelioration of Brain Infarction in Mice , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[40]  H. Holtmann,et al.  Dominance of resistance to the cytocidal effect of tumor necrosis factor in heterokaryons formed by fusion of resistant and sensitive cells. , 1988, Journal of immunology.

[41]  D. Wallach,et al.  Cell death induction by TNF: a matter of self control. , 1997, Trends in biochemical sciences.

[42]  Rena Li,et al.  Inhibition of p75 Tumor Necrosis Factor Receptor by Antisense Oligonucleotides Increases Hypoxic Injury and β-Amyloid Toxicity in Human Neuronal Cell Line* , 1997, The Journal of Biological Chemistry.

[43]  M. Mattson,et al.  Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors , 1996, Nature Medicine.

[44]  C. Saper,et al.  Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system. , 1993, The Journal of comparative neurology.

[45]  K. Frei,et al.  Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. , 1987, European journal of immunology.

[46]  R. Schreiber,et al.  Constitutive shedding of both p55 and p75 murine TNF receptors in vivo. , 1997, Journal of immunology.

[47]  S. Wesselingh,et al.  Detection of cytokine mRNA in astrocyte cultures using the polymerase chain reaction. , 1990, Lymphokine research.

[48]  E. Benveniste,et al.  Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. , 1990, Journal of immunology.

[49]  B. Beutler,et al.  Tumor Necrosis Factor: The molecules and Their Emerging Role in Medicine , 1992 .

[50]  K. Tracey,et al.  Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[51]  L. Tartaglia,et al.  Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. , 1993, Journal of immunology.

[52]  M. Shin,et al.  Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. , 1987, Journal of immunology.

[53]  A. Czurkó,et al.  Pathophysiological process after transient ischemia of the middle cerebral artery in the rat , 1994, Brain Research Bulletin.

[54]  T. Marunouchi,et al.  Production of tumor necrosis factor-alpha by microglia and astrocytes in culture , 1989, Brain Research.

[55]  T. Yue,et al.  Expression of Interleukin-6, c-Fos, and zif268 mRNAs in Rat Ischemic Cortex , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[56]  D. Spriggs,et al.  Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[57]  M. Wadhwa,et al.  Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production , 1991, Journal of Neuroimmunology.

[58]  W. Fiers,et al.  Two tumour necrosis factor receptors: structure and function. , 1995, Trends in cell biology.

[59]  H. Loetscher,et al.  Tumor necrosis factor receptors-structure and function , 1992, Immunologic research.

[60]  K. Frei,et al.  Macrophage‐induced cytotoxicity of N‐methyl‐D‐aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines , 1992, European journal of immunology.

[61]  Z. Eshhar,et al.  Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this protein. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[62]  J. Bénavidès,et al.  Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand , 1993, Journal of Neuroimmunology.

[63]  A. Sauter,et al.  Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat , 1996, Neuroscience.

[64]  Shuxian Hu,et al.  Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. , 1994, Developmental neuroscience.